Literature DB >> 23971446

Malignant incidental extracardiac findings on cardiac CT: systematic review and meta-analysis.

Nicola Flor1, Giovanni Di Leo, Silvia Amaryllis Claudia Squarza, Silvia Tresoldi, Eliana Rulli, Gianpaolo Cornalba, Francesco Sardanelli.   

Abstract

OBJECTIVE: The objective of our study was to systematically review the evidence on incidental extracardiac findings on cardiac CT with a focus on previously unknown malignancies.
MATERIALS AND METHODS: A systematic search was performed (PubMed, EMBASE, Cochrane databases) for studies reporting incidental extracardiac findings on cardiac CT. Among 1099 articles initially found, 15 studies met the inclusion criteria. The references of those articles were hand-searched and 14 additional studies were identified. After review of the full text, 10 articles were excluded. Nineteen studies including 15,877 patients (64% male) were analyzed. A three-level analysis was performed to determine the prevalence of patients with incidental extracardiac findings, the prevalence of patients with major incidental extracardiac findings, and the prevalence of patients with a proven cancer. Heterogeneity was explored for multiple variables. Pooled prevalence and 95% CI were calculated.
RESULTS: The prevalence of both incidental extracardiac findings and major incidental extracardiac findings showed a high heterogeneity (I2>95%): The pooled prevalence was 44% (95% CI, 35-54%) and 16% (95% CI, 14-20%), respectively. No significant explanatory variables were found for using or not using contrast material, the size of the FOV, and study design (I2>85%). The pooled cancer prevalence for 10 studies including 5082 patients was 0.7% (95% CI, 0.5-1.0%), with an almost perfect homogeneity (I2<0.1%). Of 29 reported malignancies, 21 (72%) were lung cancers; three, thyroid cancers; two, breast cancers; two, liver cancers; and one, mediastinal lymphoma.
CONCLUSION: Although the prevalence of reported incidental extracardiac finding at cardiac CT was highly variable, a homogeneous prevalence of previously unknown malignancies was reported across the studies, for a pooled estimate of 0.7%; more than 70% of these previously unknown malignancies were lung cancers. Extracardiac findings on cardiac CT require careful evaluation and reporting.

Entities:  

Mesh:

Year:  2013        PMID: 23971446     DOI: 10.2214/AJR.12.10306

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  18 in total

1.  Under-reporting of cardiovascular findings on chest CT.

Authors:  Nicola Sverzellati; Teresa Arcadi; Luca Salvolini; Roberto Dore; Maurizio Zompatori; Manuela Mereu; Giuseppe Battista; Ilenia Martella; Francesco Toni; Luciano Cardinale; Erica Maffei; Fabio Maggi; Filippo Cademartiri; Tommaso Pirronti
Journal:  Radiol Med       Date:  2015-10-30       Impact factor: 3.469

2.  Extracardiac findings on computed tomography attenuation correction: Is it worth paying extra attention?

Authors:  Dominik C Benz; Tobias A Fuchs
Journal:  J Nucl Cardiol       Date:  2017-05-08       Impact factor: 5.952

Review 3.  Imaging-based screening: understanding the controversies.

Authors:  Diana L Lam; Pari V Pandharipande; Janie M Lee; Constance D Lehman; Christoph I Lee
Journal:  AJR Am J Roentgenol       Date:  2014-11       Impact factor: 3.959

4.  Prognostic value of coronary CTA vs. exercise treadmill testing: results from the Partners registry.

Authors:  Michael K Cheezum; Prem Srinivas Subramaniyam; Marcio S Bittencourt; Edward A Hulten; Brian B Ghoshhajra; Nishant R Shah; Daniel E Forman; Jon Hainer; Marcia Leavitt; Ram Padmanabhan; Hicham Skali; Sharmila Dorbala; Udo Hoffmann; Suhny Abbara; Marcelo F Di Carli; Henry Gewirtz; Ron Blankstein
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-04-20       Impact factor: 6.875

5.  Collateral non cardiac findings in clinical routine CT coronary angiography: results from a multi-center registry.

Authors:  Ludovico La Grutta; Roberto Malagò; Erica Maffei; Camilla Barbiani; Andrea Pezzato; Chiara Martini; Teresa Arcadi; Alberto Clemente; Nico R Mollet; Alessandra Zuccarelli; Gabriel P Krestin; Roberto Lagalla; Roberto Pozzi Mucelli; Filippo Cademartiri; Massimo Midiri
Journal:  Radiol Med       Date:  2015-05-16       Impact factor: 3.469

6.  Incidental extra-cardiac findings on 13N-ammonia myocardial perfusion PET/CT.

Authors:  H Kan; F M van der Zant; M Wondergem; R J J Knol
Journal:  J Nucl Cardiol       Date:  2017-04-07       Impact factor: 5.952

7.  Prognostic impact of myocardial perfusion single photon emission computed tomography in patients with major extracardiac findings by computed tomography for attenuation correction.

Authors:  Charline Zadro; Noé Roussel; Emmanuelle Cassol; Pierre Pascal; Antoine Petermann; Olivier Meyrignac; Marion Jaffro; Pauline Fournier; Maxime Cournot; Michel Galinier; Didier Carrié; Hervé Rousseau; Isabelle Berry; Olivier Lairez
Journal:  J Nucl Cardiol       Date:  2017-03-09       Impact factor: 5.952

8.  Extracardiac findings on coronary computed tomography angiography in patients without significant coronary artery disease.

Authors:  Philipp Karius; Alexander Lembcke; Felix C Sokolowski; Ivan Dario Perez Gandara; Alejandra Rodríguez; Bernd Hamm; Marc Dewey
Journal:  Eur Radiol       Date:  2018-09-25       Impact factor: 5.315

9.  Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography.

Authors:  Peter Stachon; Klaus Kaier; Simone Milde; Gregor Pache; Stefan Sorg; Matthias Siepe; Constantin von zur Mühlen; Andreas Zirlik; Friedhelm Beyersdorf; Mathias Langer; Manfred Zehender; Christoph Bode; Jochen Reinöhl
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03-10       Impact factor: 6.875

10.  Incidental Findings of Pulmonary and Hilar Malignancy by Low-Resolution Computed Tomography Used in Myocardial Perfusion Imaging.

Authors:  Robert T Tung; Johannes Heyns; Lynne Dryer
Journal:  Fed Pract       Date:  2020-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.